These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7482078

  • 41. Artificial surfactant therapy for hyaline membrane disease.
    Wigglesworth JS.
    Arch Dis Child; 1980 Oct; 55(10):753-4. PubMed ID: 6893647
    [No Abstract] [Full Text] [Related]

  • 42. Pulmonary surfactant and its clinical application.
    Jin HZ.
    Chin Med J (Engl); 1991 Mar; 104(3):225-7. PubMed ID: 2065535
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB.
    Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
    Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
    [Abstract] [Full Text] [Related]

  • 47. [Administration of surfactant in hyaline membrane disease].
    Valls i Soler A.
    An Esp Pediatr; 1987 Sep; 27(3):147-51. PubMed ID: 3322119
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O, Lapillonne A, Madinier-Chappat N, Miguet D, Salle BL.
    Cah Anesthesiol; 1994 Sep; 42(3):325-8. PubMed ID: 7812856
    [Abstract] [Full Text] [Related]

  • 50. Increased survival in low birth weight neonates given prophylactic surfactant.
    Brown DR, Bloom BT, Cohen M, Myers MM, Egan EA, Kattwinkel J, Delmore P, Hall RT, Malloy MH, Holzman IR, Carlo WA, Pramanik AK, McCaffree MA, Weatherstone KB, Willett LD, Topper WH.
    J Perinatol; 1998 Sep; 18(6 Pt 1):431-5. PubMed ID: 9848755
    [Abstract] [Full Text] [Related]

  • 51. Review of experimental hyaline membrane disease.
    Robertson B.
    Diagn Histopathol; 1981 Sep; 4(1):49-60. PubMed ID: 7018865
    [Abstract] [Full Text] [Related]

  • 52. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network.
    Horbar JD, Wright EC, Onstad L.
    Pediatrics; 1993 Aug; 92(2):191-6. PubMed ID: 7710456
    [Abstract] [Full Text] [Related]

  • 53. [Problems posed by the development of exogenous surfactants for the treatment of hyaline membrane disease].
    Denizot BA, Tchoreloff PC, Bonanno LM, Proust JE, Lindenbaum A, Dehan M, Puisieux F.
    Ann Pharm Fr; 1990 Aug; 48(5):242-7. PubMed ID: 2088159
    [Abstract] [Full Text] [Related]

  • 54. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, Schulze K, Oh W, Roberts JD, Dorst JP.
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Economic outcome for intensive care of infants of birthweight 500-999 g born in Victoria in the post surfactant era. The Victorian Infant Collaborative Study Group.
    J Paediatr Child Health; 1997 Jun; 33(3):202-8. PubMed ID: 9259293
    [Abstract] [Full Text] [Related]

  • 57. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS, Ewing CK, Richards T, Taeusch HW.
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [Abstract] [Full Text] [Related]

  • 58. [Surfactant doses: From words to action].
    Boix H, Fernández C, Castillo F.
    An Pediatr (Barc); 2016 Jul; 85(1):55-6. PubMed ID: 26980470
    [No Abstract] [Full Text] [Related]

  • 59. Administration practices vary for different surfactant preparations.
    Collins MV, Braune K.
    J Obstet Gynecol Neonatal Nurs; 1990 Jul; 19(6):467-8. PubMed ID: 2088332
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.